Lexeo Therapeutics (LXEO) Prepaid Assets (2022 - 2026)
Lexeo Therapeutics' (LXEO) quarterly Prepaid Assets came in at $7.8 million in Q1 2026, up 43.65% year-on-year from $5.4 million in Q1 2025, and up 18.02% quarter-over-quarter from $6.6 million in Q4 2025.
Lexeo Therapeutics (LXEO) Prepaid Assets (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has disclosed Prepaid Assets across 5 years of filings, most recently posting $7.8 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $7.8 million, up 43.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.8 million (up 43.65% YoY), and the FY2025 annual result was $6.6 million, up 43.93% from the prior year.
- Prepaid Assets came in at $7.8 million for Q1 2026 at Lexeo Therapeutics, up from $6.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $7.8 million in Q1 2026 to a low of $371000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $3.8 million (2024), against an average of $4.1 million.
- Across the five-year window, Prepaid Assets jumped 662.26% in 2023 and soared 43.65% in 2026, its largest moves.
- Lexeo Therapeutics' Prepaid Assets stood at $371000.0 in 2022, then surged by 662.26% to $2.8 million in 2023, then jumped by 62.77% to $4.6 million in 2024, then surged by 43.93% to $6.6 million in 2025, then advanced by 18.02% to $7.8 million in 2026.
- The last three Prepaid Assets figures came in at $7.8 million (Q1 2026), $6.6 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lexeo Therapeutics | 405.92 Mn | 212.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.82 Mn |
| Dec 31, 2025 | 6.63 Mn |
| Sep 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 5.44 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Dec 31, 2022 | 371,000.00 |